Investing in the
future of health-tech

Investing in innovation
for a healthier world

The JIMCO Life Sciences Fund works closely with Jameel Health, in realizing the Jameel Family ambition of accelerating access to modern medical care for those who need it most, and so actively driving toward a more inclusive approach healthcare for all.

To accomplish this, we’re investing in the future of health-tech, through thoughtfully selected venture fund investments as well as working directly with world leading partners and entrepreneurs in the field, driven by a thirst for disruptive innovation in all that we do.

In this way, the JIMCO Life Sciences Fund and Jameel Health are focused on delivering real-world tangible solutions to meet our world’s rising health demand for modern medical care.

Emerging technologies and innovative business models in these areas present significant opportunities for sustainable growth and meaningful societal benefit for underserved populations, particularly in the ‘Global South’.

This is quickly impacting the developing regulatory environment, in turn accelerating drug and device filing, registration and market authorization as well as licensing arrangements.

We seek to both invest in emerging ideas and connect businesses to new growth opportunities particularly in rapidly developing and high demand markets.

Continuing the Jameel Family’s philanthropic word that co-founded the Jameel Clinic at MIT and the Jameel Institute at Imperial College London, Jameel Health is extending this commitment to the future of health, working with the dedicated JIMCO Life Sciences Fund to accelerate the access and availability of these across the developing regions of the world an in doing so increase inclusivity for all.